Testing the ADNEX model for ovarian tumors
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial is testing how well a special ultrasound model (ADNEX) can predict whether an ovarian tumor is benign or cancerous. It helps doctors make better decisions, and it’s for people with complex ovarian tumors who speak Dutch.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have a complex ovarian tumor (not a simple cyst)
- Your ultrasound will be done using IOTA guidelines and the ADNEX model
- You understand and speak Dutch
- Your tumor does not match any of the ‘benign easy descriptor’ categories (like simple cysts or typical endometriomas), and you have no history of ovarian cancer before this ultrasound
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special ultrasound using a contrast agent can better tell if an ovarian lesion is benign or malignant. The goal is to help doctors make more accurate decisions without surgery.
This study uses ultrasound to look at how ovarian cancer affects the liver, helping doctors plan surgery better. By taking detailed pictures of the liver before surgery, they hope to improve outcomes for people with advanced or recurrent ovarian cancer.
This study uses advanced computer analysis of CT scans to help doctors plan the best treatment for advanced ovarian cancer. It is designed for patients who are about to start active treatment, such as surgery or chemotherapy.
This study is testing new blood tests that might help detect ovarian cancer earlier by looking for specific markers. It involves people with suspected ovarian cancer and healthy volunteers, and aims to improve how we diagnose the disease.
This study uses lab-grown tumor models (organoids) from your tissue or fluid sample to find the best treatment for your ovarian cancer.
This study uses lab testing to create a “map” of ovarian cancer cells one cell at a time, to better understand the disease. It likely helps researchers learn which cell types are involved, using samples collected around your surgery.
Hear when a new Ovarian cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.